Mozambique vs Small island developing states (SIDS): Tuberculosis incidence
Mozambique
361
in 2024
Small island developing states (SIDS)
163
in 2024
Mozambique rank
16th
Small island developing states (SIDS) rank
10th
Tuberculosis incidence over time
- Mozambique
- Small island developing states (SIDS)
How they compare
Mozambique currently reports 361 against 163 in Small island developing states (SIDS), a difference of 198.
That makes Mozambique's figure about 2.2 times Small island developing states (SIDS)'s.
Across all 25 years both countries report, Mozambique has been ahead every year.
Mozambique ranks 16th and Small island developing states (SIDS) ranks 10th of 198 countries.
Mozambique has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Mozambique | Small island developing states (SIDS) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 343.3 | 215.2 | 128.1 | Mozambique |
| 2010s | 360.4 | 166.3 | 194.1 | Mozambique |
| 2020s | 361 | 157.4 | 203.6 | Mozambique |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis incidence, Mozambique or Small island developing states (SIDS)?
- Mozambique, at 361 against 163 in Small island developing states (SIDS) as of 2024.
- What is the difference in tuberculosis incidence between Mozambique and Small island developing states (SIDS)?
- 198, with Mozambique ahead.
- How many years of comparable data are there for Mozambique and Small island developing states (SIDS)?
- 25 years are reported by both, from 2000 to 2024.
- How do Mozambique and Small island developing states (SIDS) rank globally for tuberculosis incidence?
- Mozambique ranks 16th and Small island developing states (SIDS) ranks 10th of 198 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Tuberculosis incidence (per 100,000 population). Statizoid refreshes it automatically from the source and publishes the full history for both places.